HLscience Co., Ltd. (KOSDAQ:A239610) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a trust agreement with Mirae Asset Daewoo Co., Ltd. The purpose of the program is to improve the shareholder value and to stabilize the stock price. The program will continue until November 17, 2017. As of May 16, 2017, the company had no shares in treasury under the dividend capacity and no shares in treasury under other capacities.
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.